Raspadskaya PAO

Chart & performance

D1W1MN

P/E

—

P/S

0.01

EPS

—

Div yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

20.96%

Revenues

Net income

CFO

Dividend

Jan 17, 202228 RUB/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.

URL

http://www.raspadskaya.ru/

IPO date

Nov 10, 2006

Employees

Domiciled in

Incorporated in

Valuation

No data to show